Boryung to step up presence in domestic market

Published: 2008-01-22 06:57:00

Updated: 2008-01-22 06:57:00

Boryung plans to solidify its market position in the domestic market by launching new drug and promoting its flagship products including Gelfos-M and Cilalong, according to a senior official who announced its management strategy for the year on January 17.

To that end, the company will release...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK